Fluorouracil, Oxaliplatin, and Pembrolizumab

About

Membership operator: AND

Therapies: 3

Therapies

Fluorouracil (tx:ncit:C505)

Oxaliplatin (tx:ncit:C1181)

Pembrolizumab (tx:ncit:C106432)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
HSE (1) HER2-negative, PD-L1 (CPS) >= 10 Adenocarcinoma of the Gastroesophageal Junction Fluorouracil, Oxaliplatin, Pembrolizumab